The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Roivant Sciences Ltd shares valued at $1,145,000 were sold by Venker Eric on Jun 20 ’25. At $11.45 per share, Venker Eric sold 100,000 shares. The insider’s holdings dropped to 1,462,223 shares worth approximately $17.03 million following the completion of this transaction.
Also, Ramaswamy Vivek sold 577,007 shares, netting a total of over 6,612,500 in proceeds. Following the sale of shares at $11.46 each, the insider now holds 37,284,108 shares.
Before that, Ramaswamy Vivek had sold 565,266 shares from its account. In a trade valued at $6,472,296, the 10% Owner traded Roivant Sciences Ltd shares for $11.45 each. Upon closing the transaction, the insider’s holdings decreased to 565,266 shares, worth approximately $441.08 million.
Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid February. As of January 05, 2024, Piper Sandler has initiated its “an Overweight” rating for ROIV. Earlier on December 12, 2023, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for ROIV stock.
Analyzing ROIV Stock Performance
On last trading session,, Roivant Sciences Ltd [NASDAQ: ROIV] rose 0.95% to $11.65. The stock’s lowest price that day was $11.485, but it reached a high of $11.675 in the same session. During the last five days, there has been a surge of approximately 0.69%. Over the course of the year, Roivant Sciences Ltd shares have jumped approximately 1.30%.
Support And Resistance Levels for Roivant Sciences Ltd (ROIV)
RSI (Relative Strength Index) is 57.75 on the 14-day chart, showing neutral technical sentiment.
Is Roivant Sciences Ltd subject to short interest?
Stocks of Roivant Sciences Ltd saw a sharp steep in short interest on 2025-06-13 dropping by -4.17 million shares to 45.06 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 49.23 million shares. A decline of -9.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.19 of the overall float, the days-to-cover ratio (short ratio) decline to 9.19.
Which companies own the most shares of Roivant Sciences Ltd (ROIV)?
In terms of Roivant Sciences Ltd share price expectations, FactSet research, analysts set an average price target of 17 in the next 12 months, up nearly 47.31% from the previous closing price of $11.54. Analysts anticipate Roivant Sciences Ltd stock to reach 20 by 2025, with the lowest price target being 12.5. In spite of this, 7 analysts ranked Roivant Sciences Ltd stock as Buy at the end of 2025. On October 17, 2023, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $17.
